<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05025267</url>
  </required_header>
  <id_info>
    <org_study_id>19.01.CA.HCN</org_study_id>
    <nct_id>NCT05025267</nct_id>
  </id_info>
  <brief_title>Ability to Meet Enteral Nutritional Needs With a Peptide-based, High Protein Formula</brief_title>
  <official_title>Prospective Study Of Ability To Meet Nutritional Needs With A Peptide-based, High Protein Enteral Formula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, open-label single-arm observational clinical trial to assess enteral&#xD;
      feeding nutrition goals with a peptide-based, high protein enteral formula.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, observational study to assess the ability to meet enteral nutrition&#xD;
      goals and tolerance of a peptide-based, high protein tube feeding product in adult, tube-fed&#xD;
      patients living in the community setting. In addition, the study will explore metabolic and&#xD;
      inflammatory markers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">October 31, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective, single-arm, non-randomized, open-label observational study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Calorie nutritional goals</measure>
    <time_frame>14 days</time_frame>
    <description>Daily percentage of calorie nutritional goals met</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Protein nutritional goals</measure>
    <time_frame>14 days</time_frame>
    <description>Daily percentage of protein nutritional goals met</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily reports of gastrointestinal intolerance</measure>
    <time_frame>14 days</time_frame>
    <description>Daily occurrence of nausea, stool frequency, stool consistency, and/or vomiting)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>14 days</time_frame>
    <description>Daily adverse event reporting</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Enteral Feeding</condition>
  <arm_group>
    <arm_group_label>Enteral Tube-fed Adults</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adults being fed an enteral formula with a feeding tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical Food: Peptide-Based Enteral Formula</intervention_name>
    <description>Will be fed exclusively the study peptide-based, high protein enteral formula via a feeding tube</description>
    <arm_group_label>Enteral Tube-fed Adults</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults with established enteral access&#xD;
&#xD;
          -  Anticipated to require enteral nutrition to provide 90% or more of their nutritional&#xD;
             needs&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Condition which contraindicates enteral feeding (i.e. intestinal obstruction)&#xD;
&#xD;
          -  Any condition that would contraindicate use of the study product&#xD;
&#xD;
          -  Patients with active colitis, radiation enteritis, SBS, undergoing active cancer&#xD;
             treatment&#xD;
&#xD;
          -  Judged to be at risk for poor compliance to the study protocol&#xD;
&#xD;
          -  Participating in a conflicting clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krysmaru Araujo Torres, MD</last_name>
    <role>Study Director</role>
    <affiliation>Nestle Health Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 23, 2021</study_first_submitted>
  <study_first_submitted_qc>August 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

